(Q43754377)

26 November 2017

Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients (English)

1 reference

26 November 2017

1 reference

1 reference

Schwartz JI

1

1 reference

26 November 2017

Agrawal NG

2

1 reference

26 November 2017

Wong PH

3

1 reference

26 November 2017

Bachmann KA

4

1 reference

26 November 2017

Porras AG

5

1 reference

26 November 2017

Miller JL

6

1 reference

26 November 2017

Ebel DL

7

1 reference

26 November 2017

Sack MR

8

1 reference

26 November 2017

Holmes GB

9

1 reference

26 November 2017

Redfern JS

10

1 reference

26 November 2017

Gertz BJ

11

1 reference

26 November 2017

1 October 2001

1 reference

The Journal of Clinical Pharmacology

26 November 2017

1 reference

26 November 2017

41

1 reference

26 November 2017

1120-1130

1 reference

26 November 2017

10

1 reference

Renal syndromes associated with nonsteroidal antiinflammatory drugs

26 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Methotrexate--the rapidly acting drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Acute renal failure due to concomitant action of methotrexate and indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Effect of aspirin and sulindac on methotrexate clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Methotrexate in rheumatoid arthritis. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Combination therapy in rheumatoid arthritis: updated systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Near fatal drug interactions with methotrexate given for psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Fatal interaction between methotrexate and naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Methotrexate toxicity precipitated by azapropazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Liquid-liquid extraction in the 96-well plate format with SRM LC/MS quantitative determination of methotrexate and its major metabolite in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

The effect of organic acids on renal clearance of methotrexate in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

Effects of celecoxib and naproxen on renal function in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012616

10.1177/00912700122012616

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference